Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.
Pieper
M
M
Scheffold
C
C
Duwe
S
S
Rossig
C
C
Bisping
G
G
Stelljes
M
M
Tedder
T F
TF
Jurgens
H
H
Berdel
W E
WE
Kienast
J
J
D018951:Antigens, CD20 / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005818:Genetic Engineering; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy*
D018951:Antigens, CD20